122 related articles for article (PubMed ID: 38101566)
1. Suppression of Overactive Insulin-Like Growth Factor 1 Attenuates Trauma-Induced Heterotopic Ossification in Mice.
Mao D; Wang K; Jiang H; Mi J; Pan X; Zhao G; Rui Y
Am J Pathol; 2024 Mar; 194(3):430-446. PubMed ID: 38101566
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 coordinates NF-κB signaling pathway to promote chondrogenic differentiation of tendon cells in heterotopic ossification.
Fu J; Zhang J; Jiang T; Ao X; Li P; Lian Z; Li C; Zhang X; Liu J; Huang M; Zhang Z; Wang L
Bone; 2022 Oct; 163():116507. PubMed ID: 35908648
[TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
[TBL] [Abstract][Full Text] [Related]
4. Galunisertib attenuates progression of trauma-induced heterotopic ossification via blockage of Smad2/3 signaling in mice.
Mao D; Mi J; Pan X; Zhao G; Rui Y
Eur J Pharmacol; 2022 Aug; 928():175109. PubMed ID: 35738451
[TBL] [Abstract][Full Text] [Related]
5. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.
Xian L; Wu X; Pang L; Lou M; Rosen CJ; Qiu T; Crane J; Frassica F; Zhang L; Rodriguez JP; Xiaofeng Jia ; Shoshana Yakar ; Shouhong Xuan ; Argiris Efstratiadis ; Mei Wan ; Xu Cao
Nat Med; 2012 Jul; 18(7):1095-101. PubMed ID: 22729283
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation.
Chen L; Jiang W; Huang J; He BC; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Wagner ER; Luo J; Tang M; Wietholt C; Luo X; Bi Y; Su Y; Liu B; Kim SH; He CJ; Hu Y; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Zhou JZ; Reid RR; Luu HH; Haydon RC; He TC; Deng ZL
J Bone Miner Res; 2010 Nov; 25(11):2447-59. PubMed ID: 20499340
[TBL] [Abstract][Full Text] [Related]
7. BMP and mTOR signaling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities?
Wu J; Ren B; Shi F; Hua P; Lin H
J Cell Biochem; 2019 Aug; 120(8):12108-12122. PubMed ID: 30989716
[TBL] [Abstract][Full Text] [Related]
8. Critical implication of the PTEN/PI3K/AKT pathway during BMP2-induced heterotopic ossification.
Dong J; Xu X; Zhang Q; Yuan Z; Tan B
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537834
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Mammalian Target of Rapamycin Signaling with Rapamycin Prevents Trauma-Induced Heterotopic Ossification.
Qureshi AT; Dey D; Sanders EM; Seavey JG; Tomasino AM; Moss K; Wheatley B; Cholok D; Loder S; Li J; Levi B; Davis TA
Am J Pathol; 2017 Nov; 187(11):2536-2545. PubMed ID: 29029772
[TBL] [Abstract][Full Text] [Related]
10. The role of the adaptive immune system in burn-induced heterotopic ossification and mesenchymal cell osteogenic differentiation.
Ranganathan K; Agarwal S; Cholok D; Loder S; Li J; Sung Hsieh HH; Wang SC; Buchman SR; Levi B
J Surg Res; 2016 Nov; 206(1):53-61. PubMed ID: 27916375
[TBL] [Abstract][Full Text] [Related]
11. Matrine attenuates heterotopic ossification by suppressing TGF-β induced mesenchymal stromal cell migration and osteogenic differentiation.
Mao D; Pan X; Rui Y; Li F
Biomed Pharmacother; 2020 Jul; 127():110152. PubMed ID: 32559842
[TBL] [Abstract][Full Text] [Related]
12. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibition of non-canonical (TAK1-mediated) BMP signaling results in reduced chondrogenic ossification and heterotopic ossification in a rat model of blast-associated combat-related lower limb trauma.
Strong AL; Spreadborough PJ; Pagani CA; Haskins RM; Dey D; Grimm PD; Kaneko K; Marini S; Huber AK; Hwang C; Westover K; Mishina Y; Bradley MJ; Levi B; Davis TA
Bone; 2020 Oct; 139():115517. PubMed ID: 32622875
[TBL] [Abstract][Full Text] [Related]
14. Leptin accelerates the pathogenesis of heterotopic ossification in rat tendon tissues via mTORC1 signaling.
Jiang H; Chen Y; Chen G; Tian X; Tang J; Luo L; Huang M; Yan B; Ao X; Zhou W; Wang L; Bai X; Zhang Z; Wang L; Xian CJ
J Cell Physiol; 2018 Feb; 233(2):1017-1028. PubMed ID: 28407241
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-Derived TGF-β and VEGF Promote the Progression of Trauma-Induced Heterotopic Ossification.
Tu B; Li J; Sun Z; Zhang T; Liu H; Yuan F; Fan C
Inflammation; 2023 Feb; 46(1):202-216. PubMed ID: 35986177
[TBL] [Abstract][Full Text] [Related]
16. Desloratadine inhibits heterotopic ossification by suppression of BMP2-Smad1/5/8 signaling.
Kusano T; Nakatani M; Ishiguro N; Ohno K; Yamamoto N; Morita M; Yamada H; Uezumi A; Tsuchida K
J Orthop Res; 2021 Jun; 39(6):1297-1304. PubMed ID: 32043642
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin F2alpha represses IGF-I-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase.
Arvisais E; Hou X; Wyatt TA; Shirasuna K; Bollwein H; Miyamoto A; Hansen TR; Rueda BR; Davis JS
Mol Endocrinol; 2010 Mar; 24(3):632-43. PubMed ID: 20160123
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways.
Tamburini J; Chapuis N; Bardet V; Park S; Sujobert P; Willems L; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
Blood; 2008 Jan; 111(1):379-82. PubMed ID: 17878402
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice.
Wang X; Li F; Xie L; Crane J; Zhen G; Mishina Y; Deng R; Gao B; Chen H; Liu S; Yang P; Gao M; Tu M; Wang Y; Wan M; Fan C; Cao X
Nat Commun; 2018 Feb; 9(1):551. PubMed ID: 29416028
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
